By Debdeep Gupta | May, 25 2026
Gujarat Themis Biosyn in focus after Rs 1,300 crore acquisition deal for Japanese firm
gujarat themis biosyn shares are likely to remain in focus on may 25 after the company announced the acquisition of 100% equity stake in microbiopharm japan co., ltd., a japan-based company with more than six decades of expertise in fermentation, microbial-based research, development, and manufacturing of pharmaceuticals and specialty chemicals.the company has signed a definitive agreement to acquire the entire shareholding of microbiopharm japan







